Last reviewed · How we verify

NCT05797142

Virtual Reality-Based Relaxation Program on Pain Intensity, Anxiety Level in Patients to be Applied With Endoscopy

Completed NA Last updated 4 April 2023
What this trial tests

NA trial testing Virtual reality glasses in Anxiety in 100 participants. Completed in 8 July 2021.

Timeline
5 May 2021
Primary endpoint
8 July 2021
8 July 2021

Quick facts

Lead sponsorIstanbul Sabahattin Zaim University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment100
Start date5 May 2021
Primary completion8 July 2021
Estimated completion8 July 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul Sabahattin Zaim University

Who can join

Adults 18 to 80, any sex, with Anxiety or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was conducted to evaluate the effect of relaxation exercise with VR (Virtual Reality) glasses on pain severity, anxiety level, physiological symptoms of anxiety and satisfaction in patients undergoing endoscopy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Virtual reality glasses

Trials testing the same drug.

Other recruiting trials for Anxiety

Currently open trials in the same condition.

Other Istanbul Sabahattin Zaim University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05797142.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing